Medical device technology company Bitulab announced on the 21st that it signed a business agreement (MOU) with Malaysian distributor Global Face for the supply of implant products and technological cooperation at the 'POST CES 2025 Gyeongbuk·Pohang Startup Global Show' held at the POSCO International Pavilion.
This agreement is part of a strategic collaboration to supply high-functional implant products to the Malaysian and Southeast Asian markets based on the femtosecond laser-based surface treatment technology developed by Bitulab.
The femtosecond laser-based technology owned by Bitulab is evaluated as a next-generation implant surface treatment technology that not only improves bone fusion but also considers biocompatibility and environmental friendliness. Through this agreement, the company plans to realize the global applicability of the technology and collaborate with Global Face in all processes including local Malaysian approval, clinical trials, and distribution.
Based on this collaboration, Bitulab plans to pursue local registration of fixed and superstructure products and expand its business throughout Southeast Asia, starting with the Malaysian market.
A company official said, “This agreement is significant in that it goes beyond simple supply and is a strategic advancement based on technology,” adding, “We plan to focus on establishing a foundation for securing competitiveness in the Southeast Asian medical device market.”
- See more related articles
You must be logged in to post a comment.